KMID : 0191120140290030405
|
|
Journal of Korean Medical Science 2014 Volume.29 No. 3 p.405 ~ p.410
|
|
Clinicopathologic Analysis of Pituitary Adenoma: A Single Institute Experience
|
|
Cho Hwa-Jin
Kim Han-Na Kwak Yoon-Jin Seo Jeong-Wook Paek Sun-Ha Sohn Chul-Ho Yun Jung-Min Kim DaSeuRan Kang Peter Park Peom Park Sung-Hye
|
|
Abstract
|
|
|
Pituitary adenoma (PA) is a common benign neuroendocrine tumor; however, the incidence and proportion of hormone-producing PAs in Korean patients remain unknown. Authors analyzed 506 surgically resected and pathologically proven pituitary lesions of the Seoul National University Hospital from 2006 to 2011. The lesions were categorized as: PAs (n = 422, 83.4%), Rathke's cleft cysts (RCCs) (n = 54, 10.6%), inflammatory lesions (n = 8, 1.6%), meningiomas (n = 4), craniopharyngiomas (n = 4), granular cell tumors (n = 1), metastatic renal cell carcinomas (n = 2), germinomas (n = 1), ependymomas (n = 1), and unsatisfactory specimens (n = 9, 1.8%). PAs were slightly more prevalent in women (M: F = 1:1.17) with a mean age of 48.8 yr (9-80 yr). Immunohistochemical analysis revealed that prolactin-producing PAs (16.6%) and growth hormone-producing adenomas (9.2%) were the most common functional PAs. Plurihormonal PAs and nonfunctioning (null cell) adenomas were found in 14.9% and 42.4% of patients with PAs, respectively. The recurrence rate of PAs was 11.1%, but nearly 0% for the remaining benign lesions such as RCCs. 25.4% of patients with PAs were treated by gamma-knife after surgery due to residual tumors or regrowth of residual tumor. In conclusion, the pituitary lesions and the proportions of hormone-producing PAs in Korean patients are similar to those of previous reports except nonfunctioning (null cell) PAs, which are unusually frequent.
|
|
KEYWORD
|
|
Pituitary Gland, Pituitary Neoplasms, Pituitary Adenoma, Clinicopathological Study, Pituitary Hormone
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|